Article Text

Download PDFPDF
Ischaemic changes during transcatheter aortic valve implantation
  1. Mohammad Alkhalil,
  2. Mark. S Spence,
  3. Colum Owens
  1. Cardiology Department, Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast, UK
  1. Correspondence to Dr Mohammad Alkhalil, Royal Victoria Hospital, Belfast BT12 6BA, UK; mak-83{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Clinical introduction

A 59-year-old woman with trisomy 21 underwent heart team discussion for symptomatic severe aortic stenosis. Investigations revealed a type I bicuspid aortic valve with minor calcification, normal coronary arteries, preserved left ventricular function and small aorta but adequate coronary height. Heart team decision, factoring patient and family preference, was for transcatheter aortic valve implantation (TAVI).

A 26 mm self-expanding valve (Evolute R, Medtronic) was directly implanted but embolised, leading to mechanical obstruction of the left coronary artery. The valve was subsequently repositioned into the ascending aorta using snares and importantly …

View Full Text


  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

  • Patient consent for publication Parental/guardian consent obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.